Your email has been successfully added to our mailing list.

×
0.00842418235877115 0.00842418235877115 0.00842418235877115 0.00842418235877115 0.00842418235877115 0.00842418235877115 0.00842418235877115 0.00842418235877115
Stock impact report

BRIEF-Alexion reaches funding agreement with NICE and NHS England for Strensiq [Reuters]

Alexion Pharmaceuticals, Inc (ALXN) 
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.alexion.com/investor-relations
Company Research Source: Reuters
BRIEF-Alexion reaches funding agreement with NICE and NHS England for Strensiq July 5 Alexion Pharmaceuticals Inc * Says has reached national funding agreement with NICE &NHS England based on Managed Access Agreement * Says Managed Access Agreement provides access to Strensiqfor patients in England with Pediatric-onset Hypophosphatasia,regardless of current ageSource text for Eikon:Further company coverage: Show less Read more
Impact Snapshot
Event Time:
ALXN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ALXN alerts
Opt-in for
ALXN alerts

from News Quantified
Opt-in for
ALXN alerts

from News Quantified